Tag: Amicus Therapeutics

business, Finance

Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) stock performance was … Continue reading Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

Adam Keintzel
Finance

Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 30,000 shares of the stock on the open market in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $10.51, for a total transaction of $315,300.00. Following the transaction, the vice president now directly owns 102,286 shares in the company, valued at approximately $1,075,026. MannKind Corporation (NASDAQ:MNKD) stock performance was … Continue reading Healthcare Most Active Stocks: MannKind Corporation (NASDAQ:MNKD), Pfizer Inc. (NYSE:PFE), Amicus Therapeutics (NASDAQ:FOLD), Geron Corporation (NASDAQ:GERN), Gilead Sciences (NASDAQ:GILD)

Jason Knox
Finance

Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

On May 9, 2014, Amicus Therapeutics, Inc. (NASDAQ:FOLD) updated its Investor Presentation for the Migalastat Monotherapy Program (the “Presentation”). The Company’s Chief Financial Officer, William D. Baird III and the Company’s Chief Operating Officer, Bradley L. Campbell, will present some or all of this Presentation to various investors in the coming months. A copy of the presentation materials is attached hereto as Exhibit 99.1. Amicus … Continue reading Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

Jayne Crisman
Finance

Micro-cap Most Volatile Stocks: Amicus Therapeutics (NASDAQ:FOLD), Synthetic Biologics Inc (NYSEMKT:SYN), IsoRay (NYSEMKT:ISR), Ultra Clean (NASDAQ:UCTT)

According to a report by Reuters on Wednesday, New Jersey-based Amicus Therapeutics Inc. (NASDAQ:FOLD) announced that in a 24-month trial, its new drug migalastat was effective at reducing abnormal fat accumulation in kidney cells compared with placebo. The drug is being considered alone and in combination therapy for treating Fabry disease, a congenital disorder that can be debilitating and even fatal. Amicus Therapeutics, Inc. (NASDAQ:FOLD) … Continue reading Micro-cap Most Volatile Stocks: Amicus Therapeutics (NASDAQ:FOLD), Synthetic Biologics Inc (NYSEMKT:SYN), IsoRay (NYSEMKT:ISR), Ultra Clean (NASDAQ:UCTT)

Jayne Crisman
Gilead Sciences GILD NASDAQ:GILD
Finance

Biotech Bullish Stocks: Can Fite Biopharma (NYSEMKT:CANF), NanoString Technologies (NASDAQ:NSTG), Amicus Therapeutics (NASDAQ:FOLD), Oncolytics Biotech (NASDAQ:ONCY)

Can-Fite BioPharma Ltd. (NYSEMKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) stock performance was 11.80% in last session and finished the day at $5.78. Traded volume was 91.85K shares … Continue reading Biotech Bullish Stocks: Can Fite Biopharma (NYSEMKT:CANF), NanoString Technologies (NASDAQ:NSTG), Amicus Therapeutics (NASDAQ:FOLD), Oncolytics Biotech (NASDAQ:ONCY)

Kristen Barton
Finance

Biotech Decliners: Peregrine Pharmaceuticals (NASDAQ:PPHM), CytRx Corporation (NASDAQ:CYTR), PTC Therapeutics (NASDAQ:PTCT), Amicus Therapeutics (NASDAQ:FOLD)

Peregrine Pharmaceuticals (NASDAQ:PPHM) announced its earnings results on Friday. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06). Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was -8.05% in last session and finished the day at $2.40. Traded volume was 14.14million shares in the last session and the average volume of the stock remained 4.31million shares. The beta of the … Continue reading Biotech Decliners: Peregrine Pharmaceuticals (NASDAQ:PPHM), CytRx Corporation (NASDAQ:CYTR), PTC Therapeutics (NASDAQ:PTCT), Amicus Therapeutics (NASDAQ:FOLD)

Kristen Barton